We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Isabel Ely, PhD

Isabel Ely, PhD profile page

Science Writer

 at Technology Networks


Isabel is a Science Writer and Editor at Technology Networks . She holds a BSc in exercise and sport science from the University of Exeter, a MRes in medicine and health and a PhD in medicine from the University of Nottingham. Her doctoral research explored the role of dietary protein and exercise in optimizing muscle health as we age.


Education


University of Nottingham  

University of Exeter  


Areas of Expertise



Got a Question for Isabel Ely, PhD?


Get in touch using the contact form linked here and we'll get back to you shortly.



Published Content
Total: 49
Digital illustration of a human figure made of glowing particles, symbolizing human molecules.
Industry Insight

How Astrophysics Is Powering Cancer Innovation

Technology Networks spoke with Dr. Irina Babina, chief executive officer of Concr, to explore the origins of the company, the science behind its platform and the tangible impact it hopes to deliver for patients and healthcare systems alike.
Illustration of a female scientist analyzing gut microbiome bacteria to study gut health.
Industry Insight

The Probiotic Designed To Work When Your Gut Is Under Attack

Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead product, FerrocalmTM, and how its innovative strategy could reshape the future of gut health.
Transparent bubble containing a 3D DNA double helix strand on a light blue background.
Industry Insight

Bacteria-Based Technology Could Revolutionize Solid Tumor Treatment

At the BioTrinity 2025 conference, Technology Networks spoke with Dr. Pedro Correa de Sampaio, co-founder and CEO of Neobe, who are utilizing synthetic biology to engineer bacteria capable of breaking down the barriers within tumors.
Scientist with white lab coat and blue gloves, pipetting into pink media next to microscope.
News

Scientists Discover Immune Cell Type is Key to Understanding Food Allergies

A new study led by researchers at NYU Langone Health has revealed that a special group of cells found in mouse intestines suppresses the immune responses caused by food protein exposure.
Female scientists conducting lab experiments with test tubes and a microscope in front of a DNA strand.
Article

A Human Physiologist’s Journey From Lab to Leadership

In this interview, Technology Networks spoke with Dr. Joanna Bowtell, professor of physiology, nutrition and metabolism, to learn more about her decorated career, from pioneering research to leadership roles.
Patient undergoing radiotherapy on head and neck.
Industry Insight

How Radiopharmaceuticals Are Revolutionizing Cancer Therapy

In this article, Technology Networks spoke with Dr. Jack Hoppin and Dr. John Babich from Ratio Therapeutics to learn more about the recent radiopharmaceutical revolution.
3D rendering of antibodies with colorful protein structures against a soft gradient background.
Industry Insight

Overcoming the Complexities of Antibody-Drug Conjugate Development

In this interview, Technology Networks spoke with Dr. Lena Jonsson, product strategy manager at Cytiva, to explore the biological, clinical and technological frontiers shaping the next generation of ADCs.
Digital illustration of a person holding a painful knee joint with inflammation, representing osteoarthritis.
Industry Insight

A New Approach to Treating Osteoarthritis

In this interview, Technology Networks spoke with Dr. Francesco Dell’Accio and Dr. Suzanne Eldridge to explore the impact of osteoarthritis on patients, the goals of ReFleks and a novel approach to repairing osteochondral defects.
Man exercising on an exercise bike.
News

Why “Weekend Warriors” Might Be Healthier Than You Think

Being physically active for just one or two days per week – known as a “weekend warrior” – may provide comparable health and life-prolonging benefits compared to smaller doses of daily physical activity.
Syringe needle inserted into vaccine vial.
Industry Insight

DNA Vaccines Offer a New Path Beyond mRNA Technology

In this interview, Technology Networks talked to Dr. Stacy Lindborg, president, chief executive officer and board member at IMUNON, Inc., who shares how its PlaCCine® platform could reshape vaccine development.
Advertisement